English

SmartCella enters agreement to advance Professor Johan Ericson’s research on cell replacement therapies for Parkinson’s disease

SmartCella granted new European patent for the Extroducer delivery platform

XyloCor and SmartCella enter into license agreement for use of the Extroducer to administer novel gene therapy XC001 to the heart

SmartCella raises EUR 50 million to accelerate growth and commercialization

Senior life science and medical specialists join SmartCella’s Board of Directors

SmartCella strengthens team with Dr Ricardo Baptista as CTO

SmartCella AB appoints Oskar Steneryd as new CFO

SmartCella obtains approval for GMP manufacturing and quality control testing of cell therapies

SmartCella strengthens team by recruiting Dr. Nina Bauer as Chief Business Officer

Niklas Prager appointed new CEO of SmartCella